Pfizer Inc at Goldman Sachs Healthcare Conference Transcript
Okay, terrific. Good morning, everyone. Welcome to our 47th Annual Global Healthcare Conference here in sunny Miami. Hopefully it stays that way.
My name is Asad Haider. I'm the Co-head of the Healthcare Research Business Unit at Goldman Sachs. I'm also the US Pharma Analyst. I'm very pleased to open the conference with Dr. Albert Bourla, CEO of Pfizer. He kicks off our conference every year, as you've been doing, Albert, very kindly over the past few years.
Thank you very much for being with us. We have a lot to get through, but maybe before I get into some of my specific questions, Albert, any high-level opening remarks from your end?
Thank you for the opportunity. I think I'm quite pleased with the way that we are executing in a strategy that I think is very solid right now. Since the changes that we did in our commercial model in the post-COVID, I think the word that stands out, it is consistency in delivering
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
